Gulden Menderes

Integrated mutational landscape analysis of uterine leiomyosarcomas

Jungmin Choi, Aránzazu Manzano, Weilai Dong et al. · Proceedings of the National Academy of Sciences · 2021 · 113 citations · Full text

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

Charles H. Li, Elena Bonazzoli, Stefania Bellone et al. · Proceedings of the National Academy of Sciences · 2018 · 94 citations · Full text

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

Luca Zammataro, Salvatore Lopez, Stefania Bellone et al. · Proceedings of the National Academy of Sciences · 2019 · 92 citations · Full text

SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression

Jonathan Black, Gulden Menderes, Stefania Bellone et al. · Molecular Cancer Therapeutics · 2016 · 91 citations · Full text

Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro

Stefania Bellone, Eliana Bignotti, Silvia Lonardi et al. · Gynecologic Oncology · 2016 · 81 citations · Full text

Tumor Biology, Uterine Tumors, Tumoral Pathology +10